Avoro Capital Advisors LLC
CIK 1633313 · Holdings on Sep 30, 2024 · First reported Nov 14, 2024
Top ten holdings
Q3 2024- UTHR14.94%
- ASND10.86%
- ARGX9.79%
- KRYS6.96%
- MDGL6.28%
- APLS4.67%
- SRPT4.65%
- RNA4.60%
- 03152W1093.61%
- ITCI3.25%
Share classes counted separately69.61%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- ASNDWeight increased · +3.24 pp7.62% → 10.86%Shares +792.23K (+18.88%)
- BMRNWeight decreased · -2.91 pp5.00% → 2.09%Shares -2.52M (-55.28%)
- UTHRWeight increased · +2.81 pp12.13% → 14.94%Shares 0 (0.00%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 29
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | UTHRUNITED THERAPEUTICS CORPCommon View history and evidence | $1.02B | 14.94% | 2.86M shares | 12.13% → 14.94%+2.81 pp 0 (0.00%) | Unchanged | ↗▾ |
| 02 | ASNDASCENDIS PHARMA A/SSponsored ADR View history and evidence | $744.89M | 10.86% | 4.99M shares | 7.62% → 10.86%+3.24 pp +792.23K (+18.88%) | Added | ↗▾ |
| 03 | ARGXARGENX SE - ADRSponsored ADR View history and evidence | $671.35M | 9.79% | 1.24M shares | 7.09% → 9.79%+2.70 pp 0 (0.00%) | Unchanged | ↗▾ |
| 04 | KRYSKRYSTAL BIOTECH INCCommon View history and evidence | $477.32M | 6.96% | 2.62M shares | 5.95% → 6.96%+1.01 pp +189.22K (+7.78%) | Added | ↗▾ |
| 05 | MDGLMADRIGAL PHARMACEUTICALS INCCommon View history and evidence | $430.59M | 6.28% | 2.03M shares | 7.67% → 6.28%-1.39 pp -26.55K (-1.29%) | Reduced | ↗▾ |
| 06 | APLSAPELLIS PHARMACEUTICALS INCCommon View history and evidence | $320.44M | 4.67% | 11.11M shares | 5.68% → 4.67%-1.01 pp 0 (0.00%) | Unchanged | ↗▾ |
| 07 | SRPTSAREPTA THERAPEUTICS INCCommon View history and evidence | $319.16M | 4.65% | 2.56M shares | 6.31% → 4.65%-1.66 pp -444.44K (-14.81%) | Reduced | ↗▾ |
| 08 | RNAAVIDITY BIOSCIENCES INCCommon View history and evidence | $315.77M | 4.60% | 6.88M shares | 3.54% → 4.60%+1.06 pp +370.00K (+5.69%) | Added | ↗▾ |
| 09 | 03152W109AMICUS THERAPEUTICS INCCommon View history and evidence | $247.51M | 3.61% | 23.18M shares | 3.62% → 3.61%-0.01 pp -4.22M (-15.42%) | Reduced | ↗▾ |
| 10 | ITCIINTRA-CELLULAR THERAPIES INCCommon View history and evidence | $223.17M | 3.25% | 3.05M shares | 2.74% → 3.25%+0.51 pp +50.00K (+1.67%) | Added | ↗▾ |
Options overlay 1
$125.00K notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
INSMINSMED INCCommon View history and evidence | Put | 50.00K | $125.00K | +50.00K | ▾ |
1 / 1 options · preview only
Exited positions 6
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| 15678U128 CEREVEL THERAPEUTICS HOLDING | Non-derivative | -7,539,547 | -$308.29M | SEC filing ↗ | SEC filing ↗ |
| XBI SS SPDR S&P BIOTECH ETF | Non-derivative | -3,035,000 | -$281.37M | SEC filing ↗ | SEC filing ↗ |
| ALNY ALNYLAM PHARMACEUTICALS INC | Non-derivative | -400,000 | -$97.20M | SEC filing ↗ | SEC filing ↗ |
3 / 6 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1633313 · Period 2024-09-30
Data loaded 2026-09-23 · First reported 2024-11-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 6858151355
}Research all 36 reported holdings.
This page includes 30 of 36 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 36 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1633313","quarter":"2024Q3","page_size":100}
get_institutional_manager_history
{"cik":"1633313","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.